Abstract
Objectives The current study aims to evaluate the prevalence of anosmia and the factors affecting it in coronavirus disease 2019 (COVID‑19)‑confirmed cases. Patients and methods A cross‑sectional, multicenter study was conducted on 400 COVID‑19‑confirmed patients. The clinical data were collected from patients, either hospitalized in COVID‑19 units of different isolation hospitals or home‑quarantined, in Egypt. Data were collected through a predesigned survey‑based 16 questionnaire, available in two forms, one in a written form and the other was online‑designed by Google forms. Results The prevalence of anosmia was 68.8% in COVID‑19‑confirmed cases. About 41.1% of the patients had isolated anosmia. There were no significant differences between those with anosmia and those without as regards smoking and chronic rhinological status, P values were 0.118 and 0.132, respectively. Conclusion As a prevalent symptom of COVID‑19 patients, anosmia will raise the suspicion index of health staff in developing countries with limited access to the COVID‑19 test. Keywords: COVID-19, Anosmia, Corona virus.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
